Skip to main content
Log in

Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue

  • Article
  • Published:
Pathology & Oncology Research

Abstract

The aim of this study was to investigate the expression of Ki-67, bcl-2 and p53 in parathyroid adenomas and their residual rim of normal parathyroid tissue. Specimens from 26 parathyroid adenomas were studied by immunohistochemical analysis for Ki-67, bcl-2 and p53 expression. Positive findings were noted for p53 in 4 (15%) adenomas and none of the residual rims of normal parathyroid tissue (p = 0.055); for Ki-67 in 15 (56%) adenomas and none of the residual rims of normal parathyroid tissue (p = 0.00002); and for bcl-2 in 19 (73%) adenomas and 8 (31%) residual rims of normal parathyroid tissue (p < 0.01). The high rate of Ki-67 expression may indicate susceptibility of parathyroid adenomas to clonal proliferation. The weak immunoreactive expression of p53, combined with a relatively strong expression of bcl-2, may contribute to the characteristic slow progression of these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abbona GC, Papotti M, Gasparri G, et al: Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 26:135–138, 1995

    Article  PubMed  CAS  Google Scholar 

  2. Arnold A, Staunton CE, Kim HG, et al: Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 318: 658–662, 1988

    PubMed  CAS  Google Scholar 

  3. Arnold A, Kim HG: Clonal loss of one chromosome 11 in a parathyroid adenoma. J Clin Endocrinol Metab 69:496–499, 1989

    PubMed  CAS  Google Scholar 

  4. Carson DA, Ribeiro JM: Apoptosis and disease. Lancet 341:1251–1254, 1993

    Article  PubMed  CAS  Google Scholar 

  5. Cryns VL, Rubio MP, Thor AD, et al: p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 78:1320–1324, 1994

    Article  PubMed  CAS  Google Scholar 

  6. Dervan PA, Magee HM, Buckley C, et al: Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Am J Clin Pathol 97:S21–28, 1992

    Google Scholar 

  7. Ghandur-Mnaymneh L, Kimura N: The parathyroid adenoma. A histopathologic definition with a study of 172 cases of primary hyperparathyroidism. Am J Pathol 115:70–83, 1984

    PubMed  CAS  Google Scholar 

  8. Greenblatt MS, Bennett WP, Hollstein M, et al: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:855–4878, 1994

    Google Scholar 

  9. Gulkesen KH, Kilicarslan B, Altunbas HA, et al: EGFR and p53 expression and proliferative activity in parathyroid adenomas; an immunohistochemical study. APMIS 109:870–874, 2001

    Article  PubMed  CAS  Google Scholar 

  10. Hakim JP, Levine MA: Absence of p53 point mutations in parathyroid adenoma and carcinoma. J Clin Endocrinol Metab 78:103–106, 1994

    Article  PubMed  CAS  Google Scholar 

  11. Hockenbery DM, Zutter M, Hickey W, et al: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961–6965, 1991

    Article  PubMed  CAS  Google Scholar 

  12. Hollstein MC, Peri L, Mandard AM, et al: Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res 51:4102–4106, 1991

    PubMed  CAS  Google Scholar 

  13. Karak AK, Sarkar C, Chumber S, Tandon N: MIB-1 proliferative index in parathyroid adenoma & hyperplasia. Ind J Med Res 105: 235–238, 1997

    CAS  Google Scholar 

  14. Kayath MJ, Martin LC, Vieira JG, et al: A comparative study of p53 immunoexpression in parathyroid hyperplasias secondary to uremia, primary hyperplasias, adenomas and carcinomas. Eur J Endocrinol 139:78–83, 1998

    Article  PubMed  CAS  Google Scholar 

  15. Kishikawa S, Shan L, Ogihara K, et al: Overexpression and genetic abnormality of p53 in parathyroid adenomas. Pathol Int 49:853–857, 1999

    Article  PubMed  CAS  Google Scholar 

  16. LeBrun DP, Warnke RA, Cleary ML: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142:743–753, 1993

    PubMed  CAS  Google Scholar 

  17. Lloyd RV, Carney A, Ferreio JA, et al: Immunohistochemical Analysis of the cell cycle-associated antigens ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas. Endocrine Pathol 6: 279–287, 1995

    Article  Google Scholar 

  18. Loda M, Lipman J, Cukor B, et al: Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity. Hum Pathol 25:1050–1056, 1994

    Article  PubMed  CAS  Google Scholar 

  19. Lu QL, Abel P, Foster CS, et al: bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 27:102–110, 1996

    Article  PubMed  CAS  Google Scholar 

  20. Martin LN, Kayath MJ, Vieira JG, et al: Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis. Histopathology 33:46–51, 1998

    PubMed  CAS  Google Scholar 

  21. Naccarato AG, Marcocci C, Miccoli P, et al: Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues. J Endocrinol Invest 21:136–141, 1998

    PubMed  CAS  Google Scholar 

  22. Nigro JM, Baker SJ, Preisinger AC, et al: Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705–708, 1989

    Article  PubMed  CAS  Google Scholar 

  23. Novack DV, Korsmeyer SJ: Bcl-2 protein expression during murine development. Am J Pathol 145:61–73, 1994

    PubMed  CAS  Google Scholar 

  24. Ricci F, Mingazzini PL, Sebastiani V, et al: p53 as a marker of differentiation between hyperplastic and adenomatous parathyroids. Ann Diagn Pathol 6:229–235, 2002

    Article  PubMed  Google Scholar 

  25. Stojadinovic A, Hoos A, Nissan A, et al: Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol 34:54–64, 2003

    Article  PubMed  Google Scholar 

  26. Szende B, Farid P, Vegso G, et al: Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Pathol Oncol Res 10: 98–103, 2004

    Article  PubMed  CAS  Google Scholar 

  27. Szende B: The occurrence and significance of apoptosis in tumors. Magy Onkol 48: 215–219, 2004

    PubMed  Google Scholar 

  28. Tsujimoto Y, Cossman J, Jaffe E, et al: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440–1443, 1985

    Article  PubMed  CAS  Google Scholar 

  29. Vargas MP, Vargas HI, Kleiner DE, et al: The role of prognostic markers (MIB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Mod Pathol 10:12–17, 1997

    PubMed  CAS  Google Scholar 

  30. Wang W, Johansson H, Kvasnicka T, et al: Detection of apoptotic cells and expression of Ki-67 antigen, Bcl-2, p53 oncoproteins in human parathyroid adenoma. APMIS 104:789–796, 1996

    Article  PubMed  CAS  Google Scholar 

  31. Williams GT: Programmed cell death: apoptosis and oncogenesis. Cell 65:1097–1098, 1991

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rumelia Koren.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hadar, T., Shvero, J., Yaniv, E. et al. Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue. Pathol. Oncol. Res. 11, 45–49 (2005). https://doi.org/10.1007/BF03032405

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03032405

Key words

Navigation